AST5902 (trimesylate)

Product Specifications

CAS Number

2929417-90-1

Target

Drug Metabolite|||EGFR

Related Pathways

Angiogenesis|||Metabolism|||JAK/STAT signaling|||Tyrosine Kinase/Adaptors

Bioactivity

AST5902 trimesylate is the primary metabolite of Alflutinib (AST2818) both in vivo and in vitro. It exhibits antitumor activity. Alflutinib functions as an EGFR inhibitor.

Smiles

O=C(NC1=CC(NC2=NC(C3=CN(C)C4=C3C=CC=C4)=CC=N2)=C(OCC(F)(F)F)N=C1N(CCNC)C)C=C.O=S(O)(C)=O.O=S(O)(C)=O.O=S(O)(C)=O

Molecular Formula

C30H41F3N8O11S3

Molecular Weight

842.884

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-20717AF350 0.1 mL

Mouse Monoclonal Cytokeratin 7 Antibody (rKRT7/8763) [Alexa Fluor 350]

Ask

View Details

NBP2-59338G 100 µL

Mouse Monoclonal HO-1/HMOX1/HSP32 Antibody (6B8-2F2) [DyLight 488]

Ask

View Details

STJ71877 100 µg

Anti-ETF-4 / TEAD2 antibody

Ask

View Details

MBS1059802-01 0.02 mg (E-Coli)

Recombinant Serratia proteamaculans NADH-quinone oxidoreductase subunit B (nuoB)

Ask

View Details

MBS1059802-02 0.1 mg (E-Coli)

Recombinant Serratia proteamaculans NADH-quinone oxidoreductase subunit B (nuoB)

Ask

View Details

MBS1059802-03 0.02 mg (Yeast)

Recombinant Serratia proteamaculans NADH-quinone oxidoreductase subunit B (nuoB)

Ask

View Details